Kinase Centric Chemical Proteomics Provides Novel Insights into Individual Cancer Biology Bernhard Kuster, Technical University Munich, speaking at Systems Biology Europe 2012
An Integrated System Using Peptide Arrays to Assess Kinase and Nuclear Receptor Activities in Clinical Samples for Biomarker Development Bertrand Jordan, Aix-Marseille University, speaking at Microarray World Congress 2012
Identification of a Prognostic Protein Profile for Triple Negative Breast Cancer Arzu Umar, Erasmus Medical Center Rotterdam/Josephine Nefkens Institute, speaking at Systems Biology Europe 2012
Antigen Microarrays for Proteomic Profiling of the Autoimmunity Repertoire Professor Peter Nilsson, Royal Institute of Technology, Stockholm, speaking at Advances in Microarray Technology 2012.
A Mouse to Human Search for Cancer Markers Samir Hanash, Fred Hutchinson Cancer Research Center, speaking at Systems Biology Europe 2012
Actin' Out, Development of a High Content Screen Protocol for Investigation of the Interplay Between Epithelial Junctions and the Actin Cytoskeleton Dr Ann Wheeler, Queen Mary University of London, speaking at European Laboratory Automation 2012.
Next Generation X-Aptamers for Identification of Personalized Biomarkers in Cancer David G. Gorenstein, Ph.D., University of Texas Health Sciences Center, speaking at Genomics Research 2012.
Genomic and Proteomic Biomarkers for Cardiac and Renal Transplantation: Computational Biomarker Pipeline from Discovery to Clinical Implementation Dr. Robert McMaster, Professor, University of British Columbia, speaking at Genomics Research 2012.
Signalling Molecules as Proteomic Biomarkers in Brain Tumours Radu Albulescu talking on behalf of Cristiana Tanase MD, PhD, Victor Babes University of Medicine and Pharmacy, Timisoara, speaking at Molecular Diagnostics Europe 2012.